Lenvatinib 4 Mg Tablet | Jasgur Life Sciences
Lenvatinib is FDA-approved for the treatment of radioactive iodine-refractory differentiated thyroid cancer (DTC), unresectable or advanced hepatocellular carcinoma (HCC), and advanced renal cell carcinoma (RCC). It is a multiple receptor tyrosine kinase inhibitor that demonstrates potent antiangiogenic properties.
https://jasgurlifescience.com/oncology/lenvabuzz
https://jasgurlifescience.com
Abiraterone 250 Mg Tablet | Jasgur Life Sciences
Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. Abiraterone is in a class of medications called androgen biosynthesis inhibitors.
https://jasgurlifescience.com/oncology/abirabuzz
https://jasgurlifescience.com